Safety and Drug Levels of AD-123 in Healthy Adults
Part of Hormones & metabolism clinical trials.
This early-stage study tests a new medicine called AD-123 and compares how the body processes it versus two other medicines given together. Researchers will monitor your health and measure drug levels in your blood to make sure it's safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 19 or older
- Healthy (no serious medical conditions)
- Body mass index (BMI, a measure of weight relative to height) between 18.0 and 30.0
- Have not participated in another drug study within the past 6 months
- Willing to provide blood samples and attend study visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.
This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.
This trial tests the safety and how the body processes three common diabetes medications (dapagliflozin, linagliptin, and metformin) when taken together. Healthy volunteers are needed to help researchers understand how these drugs work in the body.
This early-stage trial tests how a new drug called AD-230 moves through the body and whether it's safe in healthy volunteers. Researchers will measure drug levels in your blood and watch for any side effects.
This study tests how the body handles three diabetes medicines (dapagliflozin, linagliptin, and metformin) when taken with food. It is for healthy volunteers to check safety and drug levels.
This trial studies how two experimental drugs (AD-2321 and AD-2322) interact in the body and if they are safe for healthy volunteers. It is a Phase 1 study open to healthy adults.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.